“Initial concerns about medical cannabis legalization leading to increases in medical care costs, which would be reflected in higher insurance premiums, appear to be unfounded,” authors concluded.
Investigators concluded, "Given the expanding access to cannabis products in the United States and around the world, more research, particularly longitudinal and experimental studies, is needed.”